Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$8.1M
1 round on record
Latest round
$8.1M
Series A · Feb 2026 · 7 mo ago
Team
11-50
employees, estimated range
Backers
3
AgFunder, Future Planet Capital
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Feb 2026 | $8.1M | Corteva lead | Bolsamania |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Verinomics combines cutting-edge trait discovery with precision breeding and gene editing, delivering scalable, customizable solutions…

THE PLASTOMICS' ADVANTAGE. NATURAL EFFICIENCY Plastomics is developing a novel trait delivery technology that places beneficial traits in…

Greeneye Technology retrofits commercial sprayers with artificial intelligence for spot spraying weeds. Its system distinguishes weeds from…

We empower growers to adopt plasma technology as a natural, residue-free alternative to chemical fungicides. We develop innovative…

With the Fryd app, you'll harvest more vegetables than ever! Uncover the secrets to optimizing your garden beds with mixed crops – all 100%…

UK supplier of cutting-edge pheromone technology for sustainable pest control. Supporting growers with targeted, eco-friendly lures and…
News
Resurrect Bio: $10.3 Million Oversubscribed Series A Raised To Accelerate Crop Disease Resistance
Resurrect Bio, a biotechnology company developing disease-resistant crops through gene editing, announced the final close of its Series A funding round at $10.3 million, oversubscribed from the company's previously announced $8.1 million initial close in
Read more
Report
Resurrect Bio Raises $8.1 Million Initial Close Of Series A Led By Corteva
Resurrect Bio announced the $8.1 million initial close of its Series A funding round, led by Corteva through its Corteva Catalyst platform. Additional participants in the round include Calculus Capital, Pymwymic, UKI2S, SynBioVen, and AgFunder.
Read more
Report
Resurrect Bio announces $8.1M initial close of Series A led by Corteva
/PRNewswire/ -- Resurrect Bio, a biotechnology company revolutionizing agriculture by equipping crops with genetic defenses against disease, today announced...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
Regional office
10-50 est. staff
58 Wood Lane, Scale Space, London, W12 7RZ, GB
Financials
Total raised
$8.1M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2026 | $8.1M | Details |

AgFunder
Future Planet Capital
Pymwymic